Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 595

1.

Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis.

Mistiaen W, Van Cauwelaert P, Muylaert P, Sys SU, Harrisson F, Bortier H.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1166-70.

PMID:
15052218
2.

Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis.

Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H.

J Thorac Cardiovasc Surg. 2002 Jul;124(1):146-54.

PMID:
12091820
3.

Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial prosthesis in the elderly.

Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Bortier H.

J Heart Valve Dis. 2005 Nov;14(6):774-9.

PMID:
16359058
4.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

PMID:
20303508
5.

Event status of the Starr-Edwards aortic valve to 20 years: a benchmark for comparison.

Orszulak TA, Schaff HV, Puga FJ, Danielson GK, Mullany CJ, Anderson BJ, Ilstrup DM.

Ann Thorac Surg. 1997 Mar;63(3):620-6.

PMID:
9066374
6.

Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?

Jamieson WR, Moffatt-Bruce SD, Skarsgard P, Hadi MA, Ye J, Fradet GJ, Abel JG, Janusz MT, Cheung A, Germann E.

Ann Thorac Surg. 2007 Feb;83(2):549-56; discussion 556-7.

PMID:
17257986
7.

Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis.

Accola KD, Scott ML, Palmer GJ, Thompson PA, Sand ME, Suarez-Cavalier JE, Bott JN, Ebra G.

J Heart Valve Dis. 2008 Jul;17(4):355-64; discussion 365.

PMID:
18751463
8.

Pericarbon pericardial valve prosthesis: midterm results of the aortic valve replacement.

Borowiec JW, Dubiel TW, Hansson HE, Landelius J, Nyström SO.

Angiology. 1998 Jan;49(1):1-11.

PMID:
9456159
9.

A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly.

Mistiaen W, Van Cauwelaert P, Muylaert P, De Worm E.

J Cardiovasc Surg (Torino). 2009 Apr;50(2):233-7. Epub 2008 Oct 24.

10.

Ten-year echocardiographic and clinical follow-up of aortic Carpentier-Edwards pericardial and supraannular prosthesis: a case-match study.

Le Tourneau T, Vincentelli A, Fayad G, Savoye C, Fabre OH, Prat A, Warembourg H.

Ann Thorac Surg. 2002 Dec;74(6):2010-5.

PMID:
12643388
11.

Risk factors and survival after aortic valve replacement in octogenarians.

Mistiaen W, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H.

J Heart Valve Dis. 2004 Jul;13(4):538-44.

PMID:
15311858
12.

Thrombocytopenia after aortic valve replacement with freedom solo bioprosthesis: a propensity study.

Piccardo A, Rusinaru D, Petitprez B, Marticho P, Vaida I, Tribouilloy C, Caus T.

Ann Thorac Surg. 2010 May;89(5):1425-30. doi: 10.1016/j.athoracsur.2010.01.040.

PMID:
20417755
13.

Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis.

Le Tourneau T, Marechaux S, Vincentelli A, Ennezat PV, Modine T, Polge AS, Fayad G, Prat A, Warembourg H, Deklunder G.

J Heart Valve Dis. 2007 Sep;16(5):483-8.

PMID:
17944119
14.

Performance of 21-mm size perimount aortic bioprosthesis in the elderly.

Bortolotti U, Scioti G, Milano A, De Carlo M, Codecasa R, Nardi C, Tartarini G.

Ann Thorac Surg. 2000 Jan;69(1):47-50.

PMID:
10654484
15.

Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients.

Aupart MR, Mirza A, Meurisse YA, Sirinelli AL, Neville PH, Marchand MA.

J Heart Valve Dis. 2006 Nov;15(6):768-75; discussion 775-6.

PMID:
17152784
16.

Aortic valve replacement in patients with impaired ventricular function.

Sharony R, Grossi EA, Saunders PC, Schwartz CF, Ciuffo GB, Baumann FG, Delianides J, Applebaum RM, Ribakove GH, Culliford AT, Galloway AC, Colvin SB.

Ann Thorac Surg. 2003 Jun;75(6):1808-14.

PMID:
12822620
17.

High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, et al.

J Am Coll Cardiol. 1995 Apr;25(5):1111-9.

18.

Prediction of paroxysmal atrial fibrillation after aortic valve replacement in patients with aortic stenosis: identification of potential risk factors.

Orlowska-Baranowska E, Baranowski R, Michalek P, Hoffman P, Rywik T, Rawczylska-Englert I.

J Heart Valve Dis. 2003 Mar;12(2):136-41.

PMID:
12701782
19.

Patient-prosthesis mismatch may be irrelevant after aortic valve replacement with the 19-mm Perimount pericardial bioprosthesis in patients aged 65 years or older.

Sakamoto Y, Hashimoto K, Okuyama H, Sasaki T, Takakura H, Onoguchi K.

J Artif Organs. 2007;10(4):206-11. Epub 2007 Dec 20.

PMID:
18071849
20.

Mid-term comparative follow-up after aortic valve replacement with Carpentier-Edwards and Pericarbon pericardial prostheses.

Le Tourneau T, Savoye C, McFadden EP, Grandmougin D, Carton HF, Hennequin JL, Dubar A, Fayad G, Warembourg H.

Circulation. 1999 Nov 9;100(19 Suppl):II11-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk